• Exchange: Frankfurt
  • Sector: Health Care
  • Industry: Biotech & Pharma
  • Sub-Industry: Generic Pharma

Beximco Pharmaceuticals Ltd

+ Add to Watchlist


0.204 EUR 0.001 0.49%

As of 08:42:36 ET on 10/24/2014.

Snapshot for Beximco Pharmaceuticals Ltd (R2WA)

Open: 0.210 Day's Range: 0.204 - 0.210 Volume: 0
Previous Close: 0.203 52wk Range: 0.130 - 0.257 1-Yr Rtn: +26.63%

Stock Chart for R2WA

No chart data available.
  • R2WA:GR 0.204
  • 1M
  • 1Y
Interactive R2WA Chart

Previous Close

No chart data available.
Interactive Chart
  • 1W
  • 1M
  • YTD
  • 1Y
  • 3Y
  • 5Y
Recently Viewed Symbols
Save as Watchlist
Saving as watchlist...

Key Statistics for R2WA

Current P/E Ratio (ttm) -
Estimated P/E(12/2013) -
Relative P/E vs. DAX -
Earnings Per Share (BDT) (ttm) -
Est. EPS (BDT) (12/2013) -
Est. PEG Ratio -
Market Cap (M EUR) 75.04
Shares Outstanding (M) 367.85
30 Day Average Volume 2,141
Price/Book (mrq) -
Price/Sale (ttm) -
Dividend Indicated Gross Yield 4.36%
Cash Dividend (USD) 0.0104
Dividend Ex-Date 05/14/2014
5 Year Dividend Growth 18.90%
Next Earnings Announcement -
mrq = Most Recent Quarter; ttm = Trailing Twelve Months

Income Statement for R2WA

No data available

Company Profile & Key Executives for R2WA

Beximco Pharmaceuticals Limited manufactures and sells generic pharmaceutical formulation products, active pharmaceutical ingredients (API) and intravenous (IV) fluids. The Company's product portfolio includes a variety of therapeutic categories, such as analgesics, antibiotics, cardiovascular, central nervous system, dermatology, gastrointestinal and respiratory.

Ahmed Sohail Fasihur RahmanChairmanAhmed Salman Fazlur RahmanVice Chairman
Ali NawazChief Financial OfficerRabbur RezaChief Operating Officer
More Company Profile & Key Executives for R2WA

Quotes delayed, except where indicated otherwise. All prices in local currency. Time is ET.

Sponsored Link
Sponsored Links
sec ||= nil